AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular

1. Castaño-Díez, S.
2. López-Guerra, M.
3. Zugasti, I.
4. Calvo, X.
5. Schulz, F.I.
6. Avendaño, A.
7. Mora, E.
8. Falantes, J.
9. Azaceta, G.
10. Ibáñez, M.
11. Chen, T.
12. Notario, C.
13. Amer, N.
14. Palomo, L.
15. Pomares, H.
16. Vila, J.
17. del Castillo, T.B.
18. Jiménez-Vicente, C.
19. Esteban, D.
20. Guijarro, F.
21. Álamo, J.
22. Cortés-Bullich, A.
23. Torrecillas-Mayayo, V.
24. Triguero, A.
25. Mont-De Torres, L.
26. Carcelero, E.
27. Cardús, A.
28. Germing, U.
29. Betz, B.
30. Rozman, M.
31. Arenillas, L.
32. Zamora, L.
33. Díez-Campelo, M.
34. Xicoy, B.
35. Esteve, J.
36. Díaz-Beyá, M.
37. Show all authors +

Export

Export ×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export ×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1182/BLOODADVANCES.2024013648 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus